Grey Cloak Tech Inc
Healthy Extracts Inc., through its subsidiaries, engages in the acquiring, developing, patenting, marketing, and distribution of plant-based nutraceuticals in the United States. It operates through two segments: Corporate and Health Supplements. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also prov… Read more
Grey Cloak Tech Inc (HYEX) - Net Assets
Latest net assets as of September 2025: $24.06 Million USD
Based on the latest financial reports, Grey Cloak Tech Inc (HYEX) has net assets worth $24.06 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($26.19 Million) and total liabilities ($2.13 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $24.06 Million |
| % of Total Assets | 91.87% |
| Annual Growth Rate | N/A |
| 5-Year Change | -85.62% |
| 10-Year Change | N/A |
| Growth Volatility | 17.81 |
Grey Cloak Tech Inc - Net Assets Trend (2017–2024)
This chart illustrates how Grey Cloak Tech Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Grey Cloak Tech Inc (2017–2024)
The table below shows the annual net assets of Grey Cloak Tech Inc from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $410.38K | -57.01% |
| 2023-12-31 | $954.59K | -49.18% |
| 2022-12-31 | $1.88 Million | -23.98% |
| 2021-12-31 | $2.47 Million | -13.42% |
| 2020-12-31 | $2.85 Million | +429.69% |
| 2019-12-31 | $-865.61K | +75.71% |
| 2018-12-31 | $-3.56 Million | -202.28% |
| 2017-12-31 | $-1.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Grey Cloak Tech Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1155696200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $19.65 Million | 4788.46% |
| Total Equity | $410.38K | 100.00% |
Grey Cloak Tech Inc Competitors by Market Cap
The table below lists competitors of Grey Cloak Tech Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DUG Foodtech AB (publ)
ST:VUXEN
|
$4.44 Million |
|
DRC Systems India Limited
NSE:DRCSYSTEMS
|
$4.44 Million |
|
Sunlands Technology Group
NYSE:STG
|
$4.44 Million |
|
Sphere 3D Corp
NASDAQ:ANY
|
$4.44 Million |
|
California First National Bancorp
OTCQX:CFNB
|
$4.44 Million |
|
Co-Diagnostics, Inc. Common Stock
NASDAQ:CODX
|
$4.44 Million |
|
Ravelin Properties REIT
TO:RPR-UN
|
$4.43 Million |
|
Glacier Media Inc
PINK:GLMFF
|
$4.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Grey Cloak Tech Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 954,589 to 410,377, a change of -544,212 (-57.0%).
- Net loss of 840,671 reduced equity.
- Share repurchases of 5,400 reduced equity.
- Other factors increased equity by 301,859.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-840.67K | -204.85% |
| Share Repurchases | $5.40K | -1.32% |
| Other Changes | $301.86K | +73.56% |
| Total Change | $- | -57.01% |
Book Value vs Market Value Analysis
This analysis compares Grey Cloak Tech Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 17.41x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $-1.31 | $2.39 | x |
| 2018-12-31 | $-0.55 | $2.39 | x |
| 2019-12-31 | $-0.01 | $2.39 | x |
| 2020-12-31 | $0.01 | $2.39 | x |
| 2021-12-31 | $0.01 | $2.39 | x |
| 2022-12-31 | $0.01 | $2.39 | x |
| 2023-12-31 | $0.32 | $2.39 | x |
| 2024-12-31 | $0.14 | $2.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Grey Cloak Tech Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -204.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -27.00%
- • Asset Turnover: 1.31x
- • Equity Multiplier: 5.79x
- Recent ROE (-204.85%) is below the historical average (-85.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | -2780.59% | 0.11x | 0.00x | $-3.44 Million |
| 2018 | 0.00% | -4959.73% | 0.78x | 0.00x | $-2.97 Million |
| 2019 | 0.00% | 84.55% | 0.22x | 0.00x | $719.34K |
| 2020 | -90.28% | -201.82% | 0.41x | 1.09x | $-2.86 Million |
| 2021 | -80.43% | -135.57% | 0.48x | 1.23x | $-2.23 Million |
| 2022 | -52.34% | -43.67% | 0.81x | 1.48x | $-1.17 Million |
| 2023 | -259.06% | -99.48% | 0.94x | 2.76x | $-2.57 Million |
| 2024 | -204.85% | -27.00% | 1.31x | 5.79x | $-881.71K |
Industry Comparison
This section compares Grey Cloak Tech Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Grey Cloak Tech Inc (HYEX) | $24.06 Million | 0.00% | 0.09x | $4.44 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |